Ortivus launched CoroNet in Italy and Spain

OrtivusFollowing the successful launch of CoroNet in Sweden, Ortivus now continues to build up its international sales of the system. Two of the most important markets in Europe are Italy and Spain where Ortivus now signs a partner agreement with the well-reputed and market leading company et medical devices - cardiette - CARDIOLINE.

The company, with main office in Milano, and its own subsidiaries in Spain has about 110 employees and a turnover of approximately 15 million Euro. Under the well-known brand "CARDIOLINE" et medical devices develops and promotes products such as ECG, HOLTER and STRESS-TEST solution and has a market share in Italy of approximately 40%. The company has an extensive network in Italy and Spain of cardiologists and other strategically relevant target groups for Ortivus products. In order to fully leverage on the brand recognition on the market CoroNet will be promoted under the co-brand "CARDIOLINE CoroNet".

"In et medical devices Ortivus have found a partner with a well established customer network of the kind Ortivus addresses with CoroNet. They have an organization, market presence and know-how, which fit excellent with our requirements. Furthermore, et medical's strategic decision to enlarge their portfolio with a dedicated cardiac monitoring system like CoroNet shows a top-level commitment and involvement which I believe will pay-off for both parties. We truly look forward to working together with et medical.", says Rain Eriksoo, VP Sales & Marketing at Ortivus.

"CoroNet is a strategic and hence very important addition to our overall product offering. We have scanned the market for a suitable monitoring solution to complete our portfolio and CoroNet, not only being a monitoring system but a highly innovative solution that brings an extra value to our offer and our customers is exactly what we have been looking for. With CoroNet in our portfolio we can offer our customers solutions that cover all parts of cardiology related care and improve the dissemination of our brand CARDIOLINE in the cardiology arena.", says Gian-Luca Ziliani, Marketing and Business Development Manager of et medical devices.

CoroNet is a patient monitoring system developed to specifically target hospitals and departments in the need of advanced cardiac monitoring and rehabilitation. CoroNet innovatively combines bedside and telemetry monitoring into a single seamless system. The solution has already gained a strong market share in Sweden: Karolinska in Stockholm, The University Hospital of Sahlgrenska in Gothenburg and The Academic Hospital in Uppsala are examples of prestigious hospitals that have selected Ortivus' system for their cardiology departments.

About Ortivus
Ortivus AB is a Healthcare IT company that offers information and decision-making support systems for Healthcare, Emergency Medical Services and Public Safety in Europe and North America. Ortivus AB is listed on the OMX Nordic Exchange Small Cap list and was established in 1985. Ortivus has approximately 165 employees and subsidiaries in Denmark, Germany, Great Britain, Canada, and the US. For further information please visit www.ortivus.com

About et medical Devices
et medical devices - cardiette - CARDIOLINE are highly specialized in the development, production, marketing and worldwide sales of cardiovascular technologies. The main solutions provided are integrated ECG recorders, Stress Test Systems, Holter ECG, ABPM, Defibrillators, Monitors, Rehabilitation, Selfhomecare, Telemedicine and Information Management Software. New dedicated research and development programs are progressively enlarging the products portfolio with especially patient oriented solutions. For further information please visit www.cardiette.biz www.cardioline.biz

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

AI Analysis of Colonoscopy Improves Asse…

In a new study, artificial intelligence (AI) matched and potentially exceeded the performance of gastroenterologists and conventional scoring in evaluating endoscopies of Crohn’s disease patients. The results, published in Clinical Gastroenterology...